Trending

Scott Gottlieb

FDA announces further plans to hasten digital health R&D

FDA announces further plans to hasten digital health R&D

The FDA has announced further details about its plans to hasten development of digital health products and tools.

X

FDA announces further plans to hasten digital health R&D

https://pharmaphorum.com/news/fda-announces-further-plans-to-hasten-digital-health-rd/

Gottlieb sets out vision for more transparent FDA, better rare disease guidance

Gottlieb sets out vision for more transparent FDA, better rare disease guidance

The FDA got a vote of confidence from the Trump administration when it recommended increasing its budget in

X

Gottlieb sets out vision for more transparent FDA, better rare disease guidance

https://pharmaphorum.com/news/gottlieb-sets-vision-transparent-fda-better-rare-disease-guidance/

Early approval: ‘science-based’ Gottlieb wins over sceptics

Early approval: ‘science-based’ Gottlieb wins over sceptics

After just seven months, Scott Gottlieb has stamped his own imprint on the FDA and, so far, has

X

Early approval: ‘science-based’ Gottlieb wins over sceptics

https://pharmaphorum.com/views-and-analysis/early-approval-science-based-gottlieb-wins-sceptics/

Gottlieb would rather stay at FDA – and pharma would agree

Gottlieb would rather stay at FDA – and pharma would agree

After Tom Price reached for the ejector seat two weeks ago after a scandal involving private jet use,

X

Gottlieb would rather stay at FDA – and pharma would agree

https://pharmaphorum.com/news/gottlieb-rather-stay-fda-pharma-agree/

FDA’s Gottlieb vows to close orphan drug loopholes

FDA’s Gottlieb vows to close orphan drug loopholes

FDA commissioner Scott Gottlieb is continuing his plans to streamline and accelerate the regulators’ practices, but now plans

X

FDA’s Gottlieb vows to close orphan drug loopholes

https://pharmaphorum.com/news/fdas-gottlieb-vows-close-orphan-drug-loopholes/

FDA rejects Amgen/UCB osteoporosis drug

FDA rejects Amgen/UCB osteoporosis drug

The FDA has rejected Amgen and UCB’s Evenity (romosozumab) osteoporosis drug after a late-stage trial unexpectedly highlighted a

X

FDA rejects Amgen/UCB osteoporosis drug

https://pharmaphorum.com/news/fda-rejects-amgenucb-osteoporisis-drug/

FDA can help cut drug prices, says Gottlieb

FDA can help cut drug prices, says Gottlieb

Trump’s FDA pick also vows to take on opioid addiction crisis

X

FDA can help cut drug prices, says Gottlieb

https://pharmaphorum.com/news/fda-drug-prices-scott-gottlieb/

FDA chief nominee Gottlieb reveals industry links

FDA chief nominee Gottlieb reveals industry links

Scott Gottlieb, president Donald Trump’s nomination for FDA commissioner has revealed his close links with pharma. Gottlieb has

X

FDA chief nominee Gottlieb reveals industry links

https://pharmaphorum.com/news/scott-gottlieb-reveals-industry-links/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com